6,784 Humana Inc. $HUM Shares Bought by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC grew its stake in shares of Humana Inc. (NYSE:HUM) by 27.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,429 shares of the insurance provider’s stock after acquiring an additional 6,784 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Humana were worth $11,992,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Robeco Institutional Asset Management B.V. boosted its position in shares of Humana by 9.9% in the third quarter. Robeco Institutional Asset Management B.V. now owns 2,876 shares of the insurance provider’s stock worth $1,097,000 after acquiring an additional 258 shares during the last quarter. Bank Pictet & Cie Europe AG grew its holdings in Humana by 5.8% in the third quarter. Bank Pictet & Cie Europe AG now owns 2,031 shares of the insurance provider’s stock valued at $775,000 after purchasing an additional 111 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in Humana by 1.5% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 16,661 shares of the insurance provider’s stock worth $6,357,000 after purchasing an additional 242 shares during the last quarter. Vontobel Holding Ltd. increased its position in Humana by 12.2% during the third quarter. Vontobel Holding Ltd. now owns 2,145 shares of the insurance provider’s stock worth $818,000 after purchasing an additional 234 shares during the last quarter. Finally, TD Waterhouse Canada Inc. increased its position in Humana by 2.0% during the third quarter. TD Waterhouse Canada Inc. now owns 12,056 shares of the insurance provider’s stock worth $4,575,000 after purchasing an additional 237 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on HUM shares. Wolfe Research reaffirmed an “outperform” rating and set a $450.00 price target on shares of Humana in a research note on Monday, August 24th. Bank of America upgraded shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 price target on the stock in a report on Wednesday, July 29th. Mizuho boosted their price objective on shares of Humana from $468.00 to $495.00 and gave the company an “outperform” rating in a research note on Tuesday, October 13th. Barclays boosted their price objective on shares of Humana from $515.00 to $582.00 and gave the company an “overweight” rating in a research note on Friday, October 9th. Finally, Zacks Research downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $453.30.

Humana Stock Performance

Humana stock opened at $420.97 on Friday. The firm has a market capitalization of $50.55 billion, a PE ratio of 24.73, a price-to-earnings-growth ratio of 2.62 and a beta of 0.74. Humana Inc. has a one year low of $163.11 and a one year high of $456.50. The stock’s 50 day moving average price is $397.28 and its 200 day moving average price is $350.57. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter last year, the company earned $6.27 earnings per share. As a group, sell-side analysts expect that Humana Inc. will post 9.03 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be paid a $0.8850 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.8%. Humana’s dividend payout ratio is 33.49%.

Humana Company Profile

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.